OncologyTube Professional - Patients Click Here
23,425 video views
Cancer-News: Videos
01:27
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Xofigo Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 29 views
01:24
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Stivarga Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 23 views
01:16
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Regorafenib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 18 views
01:27
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Copanlisib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 27 views
02:03
Scott Fields, M.D., SVP Head Pharmaceutical Development Oncology at Bayer Pharmaceuticals discusses Bayer Larotrectinib Program. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 46 views
02:09
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Treating Advanced Biliary Cancer: M7824 Data. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 25 views
02:10
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Pembrolizumab Monotherapy In Biliary Cancer. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 25 views
02:48
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 20 views
01:02
Do-Youn Oh, M.D., of Seoul National University Hospital discusses Future Of Biliary Cancer Treatment. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 15 views
01:12
Sanjay Popat, M.D., of The Royal Marsden Hospital Discusses ALTA-1L Trial CNS Efficacy. At ESMO Oncology Conference - Munich, Germany On October 19, 2018.
by:Cancer-News | 68 views
dsfsd